ClinicalTrials.gg
Drug

Fluocinolone Acetonide clinical trials

Also written ILUVIEN and Retisert.

studies test it
28
open now
2
in phase 3
12
first study started
2000

How each study uses Fluocinolone Acetonide is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Fluocinolone Acetonide studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
15 Feb 1963 · SYNALAR · NDA 012787 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Fluocinolone Acetonide
10
fluocinolone acetonide intravitreal implant
3
Yutiq 0.18 MG Drug Implant
2
Iluvien 0.19 MG Drug Implant
2
Tri-Luma® Cream
2

Brand

ILUVIEN
4
Retisert
3
ILUVIEN 0.19 MG
1

Other names

flucinolone acetonide
1

Studies by the year they started

28 studies that test it; most in 2008 (3)

Studies that test Fluocinolone Acetonide, by start year
YearStudies
20001
20012
20022
20031
20041
20061
20072
20083
20091
20111
20121
20142
20152
20171
20191
20201
20212
20222
20231

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
1
Phase 2
10
Phase 3
12
Phase 4
10

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 17 · Other 11

Alimera Sciences (8) · Bausch & Lomb Incorporated (5) · Galderma R&D (2) · Sanjay Asrani (1) · Texas Retina Associates (1) · EyePoint Pharmaceuticals, Inc. (1) · Glenn Jaffe (1) · Association for Innovation and Biomedical Research on Light and Image (1)

Often tested with

Tested in the same studies.

Faricimab (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test Fluocinolone Acetonide.

Studies

Open first, then newest update. How each study uses Fluocinolone Acetonide is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 28

See all 28 studies that test Fluocinolone Acetonide →

Given beside what is tested · 1 — Fluocinolone Acetonide is usual care or a partner of the new treatment

Codes

What other systems call Fluocinolone Acetonide · ClinicalTrials.gg INT007504

  • MeSH (NLM) D005446Fluocinolone AcetonideConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 0CD5FD6S2MFLUOCINOLONE ACETONIDEConfirmed FDA, NLM, Wikidata
  • RxNorm 4461Confirmed FDA, Wikidata
  • Wikidata Q924467fluocinolone acetonideConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C29055Fluocinolone AcetonideOne source FDA
  • DrugBank DB00591One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.